Toge T - Search Results

1

[Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines].

Nishiyama M, Aogi K, Saeki S, Hirabayashi N, Toge T. Nishiyama M, et al. Among authors: toge t. Gan To Kagaku Ryoho. 1991 Nov;18(14):2429-33. Gan To Kagaku Ryoho. 1991. PMID: 1952962 Japanese.

2

[Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].

Nishiyama M, Takagami S, Kirihara Y, Saeki T, Niimi K, Kim R, Jinushi K, Toge T, Niimoto M, Hattori T. Nishiyama M, et al. Among authors: toge t. Gan To Kagaku Ryoho. 1988 Aug;15(8):2285-90. Gan To Kagaku Ryoho. 1988. PMID: 3136700 Japanese.

3

[Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].

Nishiyama M, Kim R, Saeki T, Takagami S, Kirihara Y, Jinushi K, Toge T, Niimoto M, Hattori T. Nishiyama M, et al. Among authors: toge t. Gan To Kagaku Ryoho. 1988 Nov;15(11):3133-7. Gan To Kagaku Ryoho. 1988. PMID: 3142368 Japanese.

4

Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.

Noso Y, Niimi K, Nishiyama M, Hirabayashi N, Toge T, Niimoto M, Hattori T. Noso Y, et al. Among authors: toge t. Cancer Res. 1987 Dec 1;47(23):6418-22. Cancer Res. 1987. PMID: 3677085

5

[Mitomycin C and its bioreduction: relevance of NAD(P)H: quinone oxidoreductase activity to mitomycin C-induced DNA damage and cytotoxicity].

Nishiyama M, Saeki S, Aogi K, Hirabayashi N, Toge T. Nishiyama M, et al. Among authors: toge t. Gan To Kagaku Ryoho. 1993 Jun;20(8):1037-41. Gan To Kagaku Ryoho. 1993. PMID: 7685584 Japanese.

6

Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in in vitro and in vivo systems.

Nishiyama M, Saeki S, Aogi K, Hirabayashi N, Toge T. Nishiyama M, et al. Among authors: toge t. Int J Cancer. 1993 Apr 1;53(6):1013-6. doi: 10.1002/ijc.2910530626. Int J Cancer. 1993. PMID: 8473041

7

Selection of adjuvant chemotherapy for gastric cancer using objective criteria.

Nishiyama M, Toge T. Nishiyama M, et al. Among authors: toge t. Gan To Kagaku Ryoho. 1997 May;24 Suppl 1:232-8. Gan To Kagaku Ryoho. 1997. PMID: 9210903 Review.

8

Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potential.

Aogi K, Nishiyama M, Kim R, Hirabayashi N, Toge T, Mizutani A, Okada K, Sumiyoshi H, Fujiwara Y, Yamakido M, Kusano T, Andoh T. Aogi K, et al. Among authors: toge t. Int J Cancer. 1997 Jul 17;72(2):295-300. doi: 10.1002/(sici)1097-0215(19970717)72:2<295::aid-ijc16>3.0.co;2-f. Int J Cancer. 1997. PMID: 9219836

9

A role for plasma membrane potential in doxorubicin--induced cytotoxicity.

Nishiyama M, Aogi K, Saeki S, Kim R, Kuroi K, Yamaguchi Y, Toge T. Nishiyama M, et al. Among authors: toge t. Anticancer Res. 1992 May-Jun;12(3):849-52. Anticancer Res. 1992. PMID: 1622144

10

[Loco-regional cancer therapy for hepatic metastasis].

Jinushi K, Sawamura A, Aogi K, Toge T. Jinushi K, et al. Among authors: toge t. Gan To Kagaku Ryoho. 1991 Aug;18(11):1860-3. Gan To Kagaku Ryoho. 1991. PMID: 1877827 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters